Formic Acid

Formic Acid

SCHEMBL30801353

NNC(=O)Cc1ccc[n+](Cc2cn(-c3ccccc3)nn2)c1.O=CO.O=C[O-]

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.38
MAOA P21397 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 1/20 0.38
MIF P14174 3/20 0.37
CD74 P04233 1/20 0.36
CA1 P00915 4/20 0.36
CA2 P00918 4/20 0.36
CA12 O43570 3/20 0.36
CA9 Q16790 3/20 0.36
APP P05067 1/20 0.36
MMP13 P45452 1/20 0.35
GLA P06280 1/20 0.35
MEN1 O00255 1/20 0.35
POLB P06746 1/20 0.35
KMT2A Q03164 1/20 0.35
CYP19A1 P11511 1/20 0.35
MAOB P27338 1/20 0.34
AOC2 O75106 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Formic Acid SCHEMBL30801354 1.00 NOTUM (0.38) NOTUMMAOAL3MBTL1NPC1MIF
SCHEMBL23326705 0.93 MAOA (0.43) NOTUMMAOAL3MBTL1NPC1MIF
Formic Acid SCHEMBL30219804 0.82 NPSR1 (0.48) L3MBTL1CA1CA2CA12CA9
SCHEMBL23326579 0.79 GLA (0.46) NOTUMMAOAL3MBTL1NPC1MIF
Trifluoroacetic Acid SCHEMBL30801355 0.74 MIF (0.43) NOTUMMAOAL3MBTL1NPC1MIF
SCHEMBL26087979 0.73 NPSR1 (0.56) L3MBTL1MEN1KMT2AAOC2
Trifluoroacetic Acid SCHEMBL23326865 0.69 L3MBTL1 (0.43) NOTUML3MBTL1NPC1MIFCA1
Trifluoroacetic Acid SCHEMBL30801352 0.69 MIF (0.45) NOTUMMAOAL3MBTL1NPC1MIF
SCHEMBL23326867 0.68 ALDH1A1 (0.40) L3MBTL1POLBAOC2
SCHEMBL30801359 0.65 L3MBTL1 (0.55) NOTUMMAOAL3MBTL1NPC1MIF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11885818-B2 Reagent for mass spectrometry ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2024-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11885818-B2 Reagent for mass spectrometry SRMS, PTMS, MMAB NOTUM 212/4885MAOA 854/4885L3MBTL1 2526/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.